Skip to main content
Caplight Logo









NerveX Neurotechnologies

NerveX Neurotechnologies

Private
TorontoHealthcare & Life Scienceshttps://nx.vet/

Last Round

Accelerator

Mar 29, 2021

Total Funding Raised

$10,000

Company Overview

NerveX Neurotechnologies is a healthcare technology company that develops AI-powered veterinary practice management software and medical device technology to streamline clinical workflows and improve animal care.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Vertical SaaS, Medical AI, EHR & EMR

Business Model

B2B

Customer Profile

Subscription SaaS, Hardware Sales

AI Layer

Application

Keywords

veterinary practice managementveterinary AIAI scribeclinical documentationmedical transcriptionveterinary softwarevet techdigital stethoscopeSOAP notesneuromodulationSaaSpractice automationmedical deviceswearable technologytelemedicine

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

NerveX Neurotechnologies Comparables

Compare NerveX Neurotechnologies with similar companies based on industry and business-model similarity.

NerveX Neurotechnologies comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
FydoDx
84%
VetGeni
84%
VetRec
83%

NerveX Neurotechnologies Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorMar 29, 2021
GrantMar 16, 2021

Key People

Founding team and executive leadership

Mark de Wolde DVM MRCVS

Co-Founder & Chief Veterinary Officer

Founding Team

Gerard O'Leary

Co-Founder, CEO, CTO

Founding Team

NerveX Neurotechnologies Investors

Notable investors and investment history

NerveX Neurotechnologies investors
InvestorRounds
University of Toronto Early Stage TechnologyAccelerator
TIAPAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 1, 2026

    Monthly visitors grew 692% MoM, reaching 4.6K.

  • May 1, 2025

    Monthly visitors increased 627% MoM, from 330 to 2.4K.

NerveX Neurotechnologies Filings

Explore SEC and related filing metadata, where available.

NerveX Neurotechnologies filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about NerveX Neurotechnologies's valuation, stock price, and market status.

Is NerveX Neurotechnologies a public or private company?

NerveX Neurotechnologies is a private company.

What is the current stock price of NerveX Neurotechnologies?

NerveX Neurotechnologies is a private company with no public stock price. No recent secondary market data is available.

How much is NerveX Neurotechnologies worth (valuation)?

Valuation information for NerveX Neurotechnologies is not publicly available.

Can I buy NerveX Neurotechnologies stock?

NerveX Neurotechnologies shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was NerveX Neurotechnologies's last funding round?

NerveX Neurotechnologies's most recent funding round was Accelerator on March 29, 2021.

Who are the main investors in NerveX Neurotechnologies?

Key investors in NerveX Neurotechnologies include University of Toronto Early Stage Technology, TIAP.

Will NerveX Neurotechnologies IPO soon?

No public IPO plans have been announced for NerveX Neurotechnologies.

How can I track NerveX Neurotechnologies secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor NerveX Neurotechnologies's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersToronto
Employee Range7
Year Founded2021
Last FundingMar 29, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?